A Trial of Lopinavir-Ritonavir in Covid-19
Errataetall: |
CommentOn: N Engl J Med. 2020 May 7;382(19):1787-1799. - PMID 32187464 |
---|---|
Media Type: |
Electronic Article |
Year of Publication: |
2020 |
---|
Contained In: |
The New England journal of medicine - Vol. 382, No. 21 (2020), p. e68 |
---|
Language: |
English |
---|
Contributors: |
---|
Links: |
---|
Keywords: |
*Pneumonia, Viral |
---|
Notes: |
Date Completed 25.05.2020 Date Revised 19.06.2020 published: Print-Electronic CommentOn: N Engl J Med. 2020 May 7;382(19):1787-1799. - PMID 32187464 Citation Status MEDLINE Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine |
---|
Physical Description: |
Online-Ressource |
---|
doi: |
10.1056/NEJMc2008043 |
---|---|
PMID: |
32369281 |
PPN (Catalogue-ID): |
NLM310390443 |
---|
LEADER | 01952nma a2200613 c 4500 | ||
---|---|---|---|
001 | NLM310390443 | ||
003 | DE-601 | ||
005 | 20200619213838.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200505s2020 000 0 eng d | ||
024 | 7 | |a 10.1056/NEJMc2008043 |2 doi | |
028 | 5 | 2 | |a pubmed20n1237.xml |
035 | |a 10.1056/NEJMc2008043#sa1 | ||
035 | |a (DE-599)NLM32369281 | ||
040 | |b ger |c GBVCP | ||
041 | 0 | |a eng | |
100 | 1 | |a Dalerba, Piero | |
245 | 1 | 2 | |a A Trial of Lopinavir-Ritonavir in Covid-19 |h Elektronische Ressource |
300 | |a Online-Ressource | ||
500 | |a Date Completed 25.05.2020 | ||
500 | |a Date Revised 19.06.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: N Engl J Med. 2020 May 7;382(19):1787-1799. - PMID 32187464 | ||
500 | |a Citation Status MEDLINE | ||
500 | |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine | ||
611 | 2 | 7 | |a Letter |2 gnd |
611 | 2 | 7 | |a Comment |2 gnd |
653 | 2 | |a Adult |6 D000328 | |
653 | 2 | |a Betacoronavirus |6 D000073640 | |
653 | 2 | |a Coronavirus Infections |6 D018352 |a drug therapy |6 Q000188 | |
653 | 2 | |a Humans |6 D006801 | |
653 | 2 | |a Lopinavir |6 D061466 | |
653 | 2 | |a Pandemics |6 D058873 | |
653 | 2 | |a *Pneumonia, Viral |6 D011024 | |
653 | 2 | |a *Ritonavir |6 D019438 | |
655 | 7 | |a Lopinavir |2 gnd | |
655 | 7 | |a 2494G1JF75 |2 gnd | |
655 | 7 | |a Ritonavir |2 gnd | |
655 | 7 | |a O3J8G9O825 |2 gnd | |
689 | 0 | 0 | |A f |a Letter |
689 | 0 | 1 | |A f |a Comment |
689 | 0 | |5 DE-601 | |
689 | 2 | 0 | |a Lopinavir |
689 | 2 | 1 | |A r |a 2494G1JF75 |
689 | 2 | 2 | |a Ritonavir |
689 | 2 | 3 | |A r |a O3J8G9O825 |
689 | 2 | |5 DE-601 | |
700 | 1 | |a Levin, Bruce | |
700 | 1 | |a Thompson, John L | |
773 | 0 | 8 | |i in |t The New England journal of medicine |g Vol. 382, No. 21 (2020), p. e68 |q 382:21<e68 |w (DE-601)NLM00000815X |x 1533-4406 |
856 | 4 | 1 | |u http://dx.doi.org/10.1056/NEJMc2008043 |3 Volltext |
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 382 |j 2020 |e 21 |b 21 |c 05 |h e68 |